ATE445013T1 - Polypeptide und deren dna - Google Patents
Polypeptide und deren dnaInfo
- Publication number
- ATE445013T1 ATE445013T1 AT00942387T AT00942387T ATE445013T1 AT E445013 T1 ATE445013 T1 AT E445013T1 AT 00942387 T AT00942387 T AT 00942387T AT 00942387 T AT00942387 T AT 00942387T AT E445013 T1 ATE445013 T1 AT E445013T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptides
- salts
- compounds
- present
- screening
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 7
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 7
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 238000012216 screening Methods 0.000 abstract 3
- 230000000694 effects Effects 0.000 abstract 2
- 208000020084 Bone disease Diseases 0.000 abstract 1
- 208000012659 Joint disease Diseases 0.000 abstract 1
- 208000034038 Pathologic Neovascularization Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physical Education & Sports Medicine (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Rheumatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18671899 | 1999-06-30 | ||
| PCT/JP2000/004278 WO2001002564A1 (fr) | 1999-06-30 | 2000-06-29 | Nouveau polypeptide et adn de ce polypeptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE445013T1 true ATE445013T1 (de) | 2009-10-15 |
Family
ID=16193433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00942387T ATE445013T1 (de) | 1999-06-30 | 2000-06-29 | Polypeptide und deren dna |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6797483B1 (de) |
| EP (1) | EP1191099B1 (de) |
| KR (1) | KR20020026465A (de) |
| CN (1) | CN1359421A (de) |
| AT (1) | ATE445013T1 (de) |
| AU (1) | AU5705600A (de) |
| CA (1) | CA2377791A1 (de) |
| DE (1) | DE60043106D1 (de) |
| HU (1) | HUP0201660A2 (de) |
| NO (1) | NO20016344L (de) |
| PL (1) | PL353065A1 (de) |
| WO (1) | WO2001002564A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030166525A1 (en) | 1998-07-23 | 2003-09-04 | Hoffmann James Arthur | FSH Formulation |
| AU2001232967A1 (en) * | 2000-01-25 | 2001-08-07 | Hyseq, Inc. | Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides |
| AU2003250547A1 (en) * | 2002-08-05 | 2004-02-23 | Asahi Kasei Kabushiki Kaisha | Cartilage differentiation inhibiting gene |
| WO2004015078A2 (en) * | 2002-08-08 | 2004-02-19 | Nuvelo, Inc. | Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides |
| EP1610822B2 (de) | 2003-04-02 | 2018-09-19 | Ares Trading S.A. | Flüssige oder gefriergetrocknete pharmazeutische zusammensetzung enthaltend fsh und/oder lh und ein nichtionisches tensid |
| DK1638595T3 (da) | 2003-06-20 | 2013-04-08 | Ares Trading Sa | Frysetørrede FSH-/LH-formuleringer |
| CN108602866A (zh) * | 2015-09-18 | 2018-09-28 | 生命制药有限责任公司 | 通过使用cd-rap前体蛋白改善cd-rap制备过程中的表达和折叠 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3435163B2 (ja) | 1993-07-20 | 2003-08-11 | ロシュ ダイアグノスティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 黒色腫阻害蛋白質 |
| JP2001509679A (ja) * | 1997-01-21 | 2001-07-24 | ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド | レセプターをコードするポリヌクレオチドとポリペプチド |
| EP1037970A1 (de) | 1997-12-20 | 2000-09-27 | Genetics Institute, Inc. | Ausgeschiedene proteine und dafür kodierende polynukleotide |
| WO2001048203A1 (fr) | 1999-12-27 | 2001-07-05 | Takeda Chemical Industries, Ltd. | Nouvelle proteine et adn associe |
| AU2001232967A1 (en) | 2000-01-25 | 2001-08-07 | Hyseq, Inc. | Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides |
| JP6623690B2 (ja) | 2015-10-30 | 2019-12-25 | 味の素株式会社 | グルタミン酸系ｌ−アミノ酸の製造法 |
-
2000
- 2000-06-29 HU HU0201660A patent/HUP0201660A2/hu unknown
- 2000-06-29 EP EP00942387A patent/EP1191099B1/de not_active Expired - Lifetime
- 2000-06-29 WO PCT/JP2000/004278 patent/WO2001002564A1/ja not_active Ceased
- 2000-06-29 AU AU57056/00A patent/AU5705600A/en not_active Abandoned
- 2000-06-29 US US10/019,455 patent/US6797483B1/en not_active Expired - Fee Related
- 2000-06-29 PL PL00353065A patent/PL353065A1/xx unknown
- 2000-06-29 AT AT00942387T patent/ATE445013T1/de not_active IP Right Cessation
- 2000-06-29 KR KR1020017016470A patent/KR20020026465A/ko not_active Withdrawn
- 2000-06-29 CA CA002377791A patent/CA2377791A1/en not_active Abandoned
- 2000-06-29 CN CN00809843A patent/CN1359421A/zh active Pending
- 2000-06-29 DE DE60043106T patent/DE60043106D1/de not_active Expired - Lifetime
-
2001
- 2001-12-21 NO NO20016344A patent/NO20016344L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20016344D0 (no) | 2001-12-21 |
| AU5705600A (en) | 2001-01-22 |
| NO20016344L (no) | 2002-02-19 |
| EP1191099A4 (de) | 2002-08-07 |
| WO2001002564A1 (fr) | 2001-01-11 |
| PL353065A1 (en) | 2003-10-06 |
| HUP0201660A2 (en) | 2002-08-28 |
| KR20020026465A (ko) | 2002-04-10 |
| CA2377791A1 (en) | 2001-01-11 |
| DE60043106D1 (de) | 2009-11-19 |
| US6797483B1 (en) | 2004-09-28 |
| EP1191099A1 (de) | 2002-03-27 |
| CN1359421A (zh) | 2002-07-17 |
| EP1191099B1 (de) | 2009-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE364698T1 (de) | Neues, physiologisch aktives peptid und dessen verwendung | |
| DE60037836D1 (de) | ThiazoloÄ4,5-dÜpyrimidinverbindungen zur Behandlung von rheumathoider Arthritis | |
| DE69929996D1 (de) | Pharmazeutisches mittel zur behandlung von diabetes | |
| DK2157192T3 (da) | Sammensætninger til diagnose og terapi af sygdomme forbundet med afvigende ekspression af futriner (R-spondiner) | |
| DK15589A (da) | Kemiske forbindelser | |
| ATE311380T1 (de) | Durch säuregruppen disubstitierte heteroaryl- derivate und ihre verwendung als matrix metalloproteinas inhibitoren | |
| BR0213355A (pt) | composições farmacêuticas | |
| MA26608A1 (fr) | Procede de preparation d'une composition pharmaceutique destinee au traitement de l'insuffisance cardiaque. | |
| KR870700599A (ko) | 카르복실산유도체, 그의 제조방법, 이화합물을 함유한 약제조성물 및 그의 용도 | |
| DE69531004D1 (de) | p277 PEPTIDANALOGE, PHARMAZEUTISCHE ZUSAMMENSTELLUNG DAVON ZUR BEHANDLUNG UND DIAGNOSE VON DIABETES | |
| MXPA02008239A (es) | Gen humano de la esquizofrenia. | |
| SG121733A1 (en) | Nucleic acid molecules polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease | |
| SE9804212D0 (sv) | Compounds | |
| ATE445013T1 (de) | Polypeptide und deren dna | |
| BR0211635A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de um indivìduo sofrendo de ou propenso à doença de alzheimer | |
| EP1509220A4 (de) | Pharmazeutische zusammensetzung zur behandlung von seborrhoe mit 4-hydroxy-5-methoxy-4-2-methyl-3(3-methyl-2-butenyl)-2-oxiranyl -1-oxaspiro 2,5 octan-6-on | |
| DK383388D0 (da) | 3-demethyl-4-fluor-mevalonsyrederivater, deres fremstilling, farmaceutiske praeparater deraf, deres anvendelse og mellemprodukter til deres fremstilling | |
| BR9811821A (pt) | 2-acilaminopropanaminas como antagonistas de receptores de taquicinina | |
| EP0913396A3 (de) | Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen | |
| WO2001064876A3 (en) | Human schizophrenia gene | |
| DK0552765T3 (da) | benzimidazoler, farmaceutiske præparater indeholdende disse og fremgangsmåde til deres fremstilling | |
| EP0915087A3 (de) | Sulfonamid-substituierte anellierte 5-Ring-Verbindungen, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen | |
| PL336897A1 (en) | Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts | |
| DK412388D0 (da) | Leukotrienantagonister, fremgangsmaader og mellemprodukter til deres fremstilling samt deres anvendelse som laegemidler | |
| TR199902564T2 (xx) | K�k�rdak oligomer matris proteininin romatoid artrit tedavisinde kullan�m�. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |